Literature DB >> 35617423

Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis.

Christopher A Martin1,2, Daniel Pan1,2, Carl Melbourne3, Lucy Teece4, Avinash Aujayeb5, Rebecca F Baggaley1, Luke Bryant1, Sue Carr6,7, Bindu Gregary8, Amit Gupta9, Anna L Guyatt10, Catherine John10, I Chris McManus11, Joshua Nazareth1,2, Laura B Nellums12, Rubina Reza13, Sandra Simpson14, Martin D Tobin10, Katherine Woolf11, Stephen Zingwe15, Kamlesh Khunti16, Keith R Abrams17, Laura J Gray4, Manish Pareek1,2.   

Abstract

BACKGROUND: Healthcare workers (HCWs), particularly those from ethnic minority groups, have been shown to be at disproportionately higher risk of infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) compared to the general population. However, there is insufficient evidence on how demographic and occupational factors influence infection risk among ethnic minority HCWs. METHODS AND
FINDINGS: We conducted a cross-sectional analysis using data from the baseline questionnaire of the United Kingdom Research study into Ethnicity and Coronavirus Disease 2019 (COVID-19) Outcomes in Healthcare workers (UK-REACH) cohort study, administered between December 2020 and March 2021. We used logistic regression to examine associations of demographic, household, and occupational risk factors with SARS-CoV-2 infection (defined by polymerase chain reaction (PCR), serology, or suspected COVID-19) in a diverse group of HCWs. The primary exposure of interest was self-reported ethnicity. Among 10,772 HCWs who worked during the first UK national lockdown in March 2020, the median age was 45 (interquartile range [IQR] 35 to 54), 75.1% were female and 29.6% were from ethnic minority groups. A total of 2,496 (23.2%) reported previous SARS-CoV-2 infection. The fully adjusted model contained the following dependent variables: demographic factors (age, sex, ethnicity, migration status, deprivation, religiosity), household factors (living with key workers, shared spaces in accommodation, number of people in household), health factors (presence/absence of diabetes or immunosuppression, smoking history, shielding status, SARS-CoV-2 vaccination status), the extent of social mixing outside of the household, and occupational factors (job role, the area in which a participant worked, use of public transport to work, exposure to confirmed suspected COVID-19 patients, personal protective equipment [PPE] access, aerosol generating procedure exposure, night shift pattern, and the UK region of workplace). After adjustment, demographic and household factors associated with increased odds of infection included younger age, living with other key workers, and higher religiosity. Important occupational risk factors associated with increased odds of infection included attending to a higher number of COVID-19 positive patients (aOR 2.59, 95% CI 2.11 to 3.18 for ≥21 patients per week versus none), working in a nursing or midwifery role (1.30, 1.11 to 1.53, compared to doctors), reporting a lack of access to PPE (1.29, 1.17 to 1.43), and working in an ambulance (2.00, 1.56 to 2.58) or hospital inpatient setting (1.55, 1.38 to 1.75). Those who worked in intensive care units were less likely to have been infected (0.76, 0.64 to 0.92) than those who did not. Black HCWs were more likely to have been infected than their White colleagues, an effect which attenuated after adjustment for other known risk factors. This study is limited by self-selection bias and the cross sectional nature of the study means we cannot infer the direction of causality.
CONCLUSIONS: We identified key sociodemographic and occupational risk factors associated with SARS-CoV-2 infection among UK HCWs, and have determined factors that might contribute to a disproportionate odds of infection in HCWs from Black ethnic groups. These findings demonstrate the importance of social and occupational factors in driving ethnic disparities in COVID-19 outcomes, and should inform policies, including targeted vaccination strategies and risk assessments aimed at protecting HCWs in future waves of the COVID-19 pandemic. TRIAL REGISTRATION: The study was prospectively registered at ISRCTN (reference number: ISRCTN11811602).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35617423      PMCID: PMC9187071          DOI: 10.1371/journal.pmed.1004015

Source DB:  PubMed          Journal:  PLoS Med        ISSN: 1549-1277            Impact factor:   11.613


  28 in total

1.  Glossary of terms relating to ethnicity and race: for reflection and debate.

Authors:  R Bhopal
Journal:  J Epidemiol Community Health       Date:  2004-06       Impact factor: 3.710

2.  Exposure of hospital healthcare workers to the novel coronavirus (SARS-CoV-2).

Authors:  Salman Razvi; Rahima Oliver; Jonathan Moore; Andrew Beeby
Journal:  Clin Med (Lond)       Date:  2020-09-22       Impact factor: 2.659

3.  Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel.

Authors:  Jesse T Jacob; Julia M Baker; Scott K Fridkin; Benjamin A Lopman; James P Steinberg; Robert H Christenson; Brent King; Surbhi Leekha; Lyndsay M O'Hara; Peter Rock; Gregory M Schrank; Mary K Hayden; Bala Hota; Michael Y Lin; Brian D Stein; Patrizio Caturegli; Aaron M Milstone; Clare Rock; Annie Voskertchian; Sujan C Reddy; Anthony D Harris
Journal:  JAMA Netw Open       Date:  2021-03-01

4.  Ten scientific reasons in support of airborne transmission of SARS-CoV-2.

Authors:  Trisha Greenhalgh; Jose L Jimenez; Kimberly A Prather; Zeynep Tufekci; David Fisman; Robert Schooley
Journal:  Lancet       Date:  2021-04-15       Impact factor: 79.321

5.  Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study.

Authors:  Yin Mo; David W Eyre; Sheila F Lumley; Timothy M Walker; Robert H Shaw; Denise O'Donnell; Lisa Butcher; Katie Jeffery; Christl A Donnelly; Ben S Cooper
Journal:  PLoS Med       Date:  2021-10-12       Impact factor: 11.069

6.  SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.

Authors:  Christopher A Martin; Colette Marshall; Prashanth Patel; Charles Goss; David R Jenkins; Claire Ellwood; Linda Barton; Arthur Price; Nigel J Brunskill; Kamlesh Khunti; Manish Pareek
Journal:  PLoS Med       Date:  2021-11-05       Impact factor: 11.069

7.  The impact of testing and infection prevention and control strategies on within-hospital transmission dynamics of COVID-19 in English hospitals.

Authors:  Stephanie Evans; Emily Agnew; Emilia Vynnycky; James Stimson; Alex Bhattacharya; Christopher Rooney; Ben Warne; Julie Robotham
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2021-05-31       Impact factor: 6.237

8.  Lessons for managing high-consequence infections from first COVID-19 cases in the UK.

Authors:  Peter Moss; Gavin Barlow; Nicholas Easom; Patrick Lillie; Anda Samson
Journal:  Lancet       Date:  2020-02-27       Impact factor: 79.321

9.  SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.

Authors:  Adrian Shields; Sian E Faustini; Marisol Perez-Toledo; Sian Jossi; Erin Aldera; Joel D Allen; Saly Al-Taei; Claire Backhouse; Andrew Bosworth; Lyndsey A Dunbar; Daniel Ebanks; Beena Emmanuel; Mark Garvey; Joanna Gray; I Michael Kidd; Golaleh McGinnell; Dee E McLoughlin; Gabriella Morley; Joanna O'Neill; Danai Papakonstantinou; Oliver Pickles; Charlotte Poxon; Megan Richter; Eloise M Walker; Kasun Wanigasooriya; Yasunori Watanabe; Celina Whalley; Agnieszka E Zielinska; Max Crispin; David C Wraith; Andrew D Beggs; Adam F Cunningham; Mark T Drayson; Alex G Richter
Journal:  Thorax       Date:  2020-09-11       Impact factor: 9.139

10.  SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic.

Authors:  Helen Ward; Christina Atchison; Matthew Whitaker; Kylie E C Ainslie; Joshua Elliott; Lucy Okell; Rozlyn Redd; Deborah Ashby; Christl A Donnelly; Wendy Barclay; Ara Darzi; Graham Cooke; Steven Riley; Paul Elliott
Journal:  Nat Commun       Date:  2021-02-10       Impact factor: 14.919

View more
  4 in total

1.  Hesitancy for receiving regular SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis from the UK-REACH study.

Authors:  Neyme Veli; Christopher A Martin; Katherine Woolf; Joshua Nazareth; Daniel Pan; Amani Al-Oraibi; Rebecca F Baggaley; Luke Bryant; Laura B Nellums; Laura J Gray; Kamlesh Khunti; Manish Pareek
Journal:  BMC Med       Date:  2022-10-10       Impact factor: 11.150

2.  Cohort Profile: The United Kingdom Research study into Ethnicity and COVID-19 outcomes in Healthcare workers (UK-REACH).

Authors:  Luke Bryant; Robert C Free; Katherine Woolf; Carl Melbourne; Anna L Guyatt; Catherine John; Amit Gupta; Laura J Gray; Laura Nellums; Christopher A Martin; I Chris McManus; Claire Garwood; Vishant Modhawdia; Sue Carr; Louise V Wain; Martin D Tobin; Kamlesh Khunti; Ibrahim Akubakar; Manish Pareek
Journal:  Int J Epidemiol       Date:  2022-08-27       Impact factor: 9.685

3.  Speaking COVID-19: supporting COVID-19 communication and engagement efforts with people from culturally and linguistically diverse communities.

Authors:  Holly Seale; Ben Harris-Roxas; Anita Heywood; Ikram Abdi; Abela Mahimbo; Ashfaq Chauhan; Lisa Woodland
Journal:  BMC Public Health       Date:  2022-06-27       Impact factor: 4.135

4.  Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study.

Authors:  Ana Atti; Ferdinando Insalata; Edward J Carr; Ashley D Otter; Javier Castillo-Olivares; Mary Wu; Ruth Harvey; Michael Howell; Andrew Chan; Jonathan Lyall; Nigel Temperton; Diego Cantoni; Kelly da Costa; Angalee Nadesalingam; Andrew Taylor-Kerr; Nipunadi Hettiarachchi; Caio Tranquillini; Jacqueline Hewson; Michelle J Cole; Sarah Foulkes; Katie Munro; Edward J M Monk; Iain D Milligan; Ezra Linley; Meera A Chand; Colin S Brown; Jasmin Islam; Amanda Semper; Andre Charlett; Jonathan L Heeney; Rupert Beale; Maria Zambon; Susan Hopkins; Tim Brooks; Victoria Hall
Journal:  J Infect       Date:  2022-09-09       Impact factor: 38.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.